Skip to main content
Log in

Drug-Induced Tactile Hallucinations Beyond Recreational Drugs

  • Review Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

In monosymptomatic hypochondriacal psychosis (MHP), such as delusional infestation (DI), the patient has a fixed, false, encapsulated belief associated with tactile hallucinations (TH), most commonly formication, which is defined as cutaneous sensations of crawling, stinging, biting, etc., without evidence of infestation. Drug-induced TH should be considered in patients with suspected MHP. Although recreational drugs such as cocaine, amphetamines, and narcotics are well known to induce TH, many busy practicing dermatologists may not be familiar with other types of medications that can induce TH. A literature search for peer-reviewed articles was conducted in the PubMed, PsychInfo, Cochrane, and Embase databases. For each article, the medication(s) that induced TH was identified in a systematic way. The most commonly reported group of medications to induce TH was anti-Parkisonian agents, followed by antidepressants, prescription stimulants, antihypertensives (propranolol), and antiepileptics. In many cases, other types of hallucinations, such as visual and auditory, were present. Patients also commonly presented with psychiatric comorbidities. Although the conclusions that can be derived from this literature review are limited, it appears that certain medications that alter neurotransmitters, especially dopamine and, less convincingly, norepinephrine and serotonin, can be associated with TH. Drug-induced TH should also be considered in patients presenting with multiple types of hallucinations and patients with existing psychiatric comorbidity. Drug-induced TH, especially with an underlying psychiatric diagnosis that is separate from MHP, may be a more manageable disease entity compared with bona fide MHP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Vulink NC. Delusional infestation: state of the art. Acta Derm Venereol. 2016;96:58–63.

    PubMed  Google Scholar 

  2. Freudenmann RW, Lepping P. Delusional infestation. Clin Microbiol Rev. 2009;22:690–732.

    Article  PubMed  PubMed Central  Google Scholar 

  3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA): American Psychiatric Association; 2013.

    Book  Google Scholar 

  4. Koo J. Psychodermatology: a practical manual for clinicians. Curr Probl Dermatol. 1995;7:199–234.

    Article  Google Scholar 

  5. Wong JW, Koo J. Delusions of parasitosis. Indian J Dermatol. 2013;58(1):49–52.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Wykoff RF. Delusions of parasitosis: a review. Rev Infect Dis. 1987;9(3):433–7.

    Article  CAS  PubMed  Google Scholar 

  7. Goetz CG, Vogel C, Tanner CM, Stebbins GT. Early dopaminergic drug-induced hallucinations in Parkinsonian patients. Neurology. 1998;51:811–4.

    Article  CAS  PubMed  Google Scholar 

  8. Moskovitz C, Moses H, Klawans HL. Levodopa-induced psychosis: a kindling phenomenon. Am J Psych. 1978;135:669–75.

    Article  CAS  Google Scholar 

  9. Kataoka H, Sawa N, Sugie K, Ueno S. Dopamine agonists trigger tactile hallucinations in patients with Pakinson’s Disease? J Neurol Sci. 2014;347:361–3.

    Article  CAS  PubMed  Google Scholar 

  10. Flann S, Shotbolt J, Kessel B, et al. Three cases of delusional parasitosis caused by dopamine agonists. Clin Exp Dermatol. 2010;35(7):740–2.

    Article  CAS  PubMed  Google Scholar 

  11. Swick B, Walling H. Drug-induced delusions of parasitosis during treatment of Parkinson’s disease. J Am Acad Dermatol. 2005;53:1086–7.

    Article  PubMed  Google Scholar 

  12. Fénelon G, Thobois S, Bonnet AM, Broussolle E, Tison F. Tactile hallucinations in Parkinson’s disease. J Neurol. 2002;249:1699–703.

    Article  PubMed  Google Scholar 

  13. Jiménez-Jiménez FJ, Ortí-Pareja M, Gasalla T, Tallón-Barranco A, Cabrera-Valdivia F, Fernández-Lliria A. Cenesthetic hallucinations in a patient with Parkinson’s disease. J Neurol Neurosur Psychiatry. 1997;63:120.

    Article  Google Scholar 

  14. Wilcox J. Psychoactive properties of amantadine. J Psychoactive Drugs. 1985;17:51–3.

    Article  CAS  PubMed  Google Scholar 

  15. Shepherd G, Velez LI, Keyes DC. Intentional bupropion overdoses. J Emerg Med. 2004;27:147–51.

    Article  PubMed  Google Scholar 

  16. Arora GS, Arora HK, Sidhu J, Najjar F. Tactile hallucinations with fluoxetine and methylphenidate. J Child Adolesc Psychopharmacol. 2014;6:360–1.

    Article  Google Scholar 

  17. Coskun M, Zoroglu S. Tactile and visual hallucinations in a child with methylphenidate and fluoxetine combination. J Clin Psychopharmacol. 2008;28:723–5.

    Article  PubMed  Google Scholar 

  18. Charuvastra A, Yaeger D. Tactile hallucinations associated with therapeutic doses of bupropion in 2 patients. J Clin Psychiatry. 2006;67(11):1820–1.

    Article  PubMed  Google Scholar 

  19. Liskin B, Roose SP, Walsh BT, Jackson WK. Acute psychosis following phenelzine discontinuation. J Clin Psychopharm. 1985;5(1):46–7.

    Article  CAS  Google Scholar 

  20. Peabody CA. Trazodone withdrawal and formication. J Clin Psychiatry. 1987;48(9):385.

    CAS  PubMed  Google Scholar 

  21. Hvizdos AJ, Bennett JA, Wells BG, Rappaport KB, Mendel SA. Anticholinergic psychosis in a patient receiving usual doses of haloperidol, desipramine, and benztropine. Clin Pharm. 1983;2(2):174–8.

    CAS  PubMed  Google Scholar 

  22. Liebowitz MR, Nuetzel EJ, Bowser AE, Klein DF. Phenelzine and delusions of parasitosis: a case report. Am J Psychiatry. 1978;135:1422–33.

    Article  Google Scholar 

  23. Stanciu CN, Penders TM, Oxentine HN. Delusional infestation following misuse of prescription stimulants. Psychosomatics. 2015;56(2):210–2.

    Article  PubMed  Google Scholar 

  24. Buscarino M, Saal J, Young JL. Delusional parasitosis in a female treated with mixed amphetamine salts: a case report and literature review. Case Rep Psychiatry. 2012;2012:624235.

    PubMed  PubMed Central  Google Scholar 

  25. Rashid J, Mitelman S. Methylphenidate and somatic hallucinations. J Am Acad Child Psychiatry. 2007;46(8):945–6.

    Article  Google Scholar 

  26. Young JG. Methylphenidate-induced hallucinosis: case histories and possible mechanisms of action. J Dev Behav Pediatr. 1981;2:35–8.

    Article  CAS  PubMed  Google Scholar 

  27. Horn JR, Rylander ML, Hicks HM. Propranolol-induced hallucinosis. Clin Pharm. 1982;1(5):464–8.

    CAS  PubMed  Google Scholar 

  28. Kurland ML. Organic brain syndrome with propranolol. N Engl J Med. 1979;300(7):366.

    CAS  PubMed  Google Scholar 

  29. Hinshelwood RD. Hallucinations and propranolol. Br Med J. 1969;2:445.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Moreira CA, Soares AR, Maia G. Psychiatric antiepileptics side effects: a case report. Eur Psychiatry. 2016;33(Suppl):S348.

    Google Scholar 

  31. Oh HK, Tebrewal P, Dhillon R. Lamotrigine-induced tactile hallucination. J Clin Psychiatry. 2014;75(11):e1330.

    Article  PubMed  Google Scholar 

  32. Shrestha PV, Syed A, Marwaha R. Lacosamide-induced tactile hallucinations in a patient with complex partial seizures. J Neuropsychiatry Clin Neurosci. 2014;26(3):E8–9.

    Article  PubMed  Google Scholar 

  33. Mukonzo JK, Okwera A, Nakasujja N, et al. Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study. BMC Infect Dis. 2013;4(13):261.

    Article  CAS  Google Scholar 

  34. Brandt LJ. Formication and azathioprine therapy. Ann Intern Med. 1977;87(4):458.

    Article  CAS  PubMed  Google Scholar 

  35. Siemianowski LA, Rosenheck JP, Whitman CB. Nalbuphine-induced psychosis treated with naloxone. Am J Health Syst Pharm. 2014;71:717–21.

    Article  CAS  PubMed  Google Scholar 

  36. Selvaraj V, Skaf M, Sharma A, Farooq U, Frederick P. Eszopiclone-induced psychosis. Innov Clin Neurosci. 2012;9(10):11.

    PubMed  PubMed Central  Google Scholar 

  37. Patel V, Koo JY. Delusions of parasitosis: suggested dialogue between dermatologist and patient. J Dermatolog Treat. 2015;26(5):456–60.

    Article  PubMed  Google Scholar 

  38. Elpern DJ. Cocaine abuse and delusions of parasitosis. Cutis. 1988;42(4):273–4.

    CAS  PubMed  Google Scholar 

  39. Bell DS. The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry. 1973;29:35–40.

    Article  CAS  PubMed  Google Scholar 

  40. Botschev C, Müller N. Opiate receptor antagonists for delusions of parasitosis. Biol Psychiatry. 1991;30(5):530–1.

    Article  CAS  PubMed  Google Scholar 

  41. Vles J, Feron F, Hendriksen J, Jolles J, Van Kroonenburgh M, Weber W. Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit. Neuropediatrics. 2003;34:77–80.

    Article  CAS  PubMed  Google Scholar 

  42. Huber M, Kirchler E, Karner M, et al. Delusional parasitosis and the dopamine transporter. A new insight of etiology? Med Hypotheses. 2007;68:1351–8.

    Article  CAS  PubMed  Google Scholar 

  43. Gershon ES, Goldstein RE, Moss AJ, et al. Psychosis with ordinary doses of propranolol. Ann Intern Med. 1979;90:938–9.

    Article  CAS  PubMed  Google Scholar 

  44. Arensberg D, Wenger NK. Psychosis: a probable result of propranolol therapy. Int J Addict. 1979;14(6):785–7.

    Article  CAS  PubMed  Google Scholar 

  45. McGahan DJ, Wojslaw A, Prasad V, Blankenship S. Propranolol-induced psychosis. Ann Pharmacother. 1984;18(7–8):601–3.

    Article  CAS  Google Scholar 

  46. Huffman JC, Stern TA. Neuropsychiatric consequences of cardiovascular medications. Dialogues Clin Neurosci. 2007;9(1):29–45.

    PubMed  PubMed Central  Google Scholar 

  47. Glennon RA, Titeler M, McKenney JD. Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci. 1984;35:2505–11.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mio Nakamura.

Ethics declarations

Funding

No funding was received for the preparation of this review.

Conflict of interest

Mio Nakamura and John Koo have no conflicts of interest to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nakamura, M., Koo, J. Drug-Induced Tactile Hallucinations Beyond Recreational Drugs. Am J Clin Dermatol 17, 643–652 (2016). https://doi.org/10.1007/s40257-016-0219-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40257-016-0219-z

Keywords

Navigation